Skip to main content
. 2021 Jun 2;10(11):2463. doi: 10.3390/jcm10112463

Table 3.

Detailed description of bleeding (BARC1).

BARC 1
(n = 10)
No Bleeding
(n = 170)
p
Femoral approach, n (%) 7 (70%) 39 (22.9%) 0.001
Concomitant DAPT use, n (%) 7 (70%) 68 (40%) 0.061
History of previous hemorrhage, n (%) 0 3 (1.8%) 0.672
Type of stent, n (%) 0.052
BMS 1 (10%) 76 (44.7%)
DES 8 (80%) 90 (52.9%)
DES + BMS 1 (10%) 4 (2.4%)

BARC, Bleeding Academic Research Consortium; DAPT, dual antiplatelet therapy; BMS, bare metal stent; DES, drug-eluting stent.